Sanofi Loses iGlarLixi Advantage Over Novo's iDegLira Amid Pen Problems

 
• By Derrick Gingery
  
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet